Cite
HARVARD Citation
Mateos, M. et al. (n.d.). Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial. Lancet oncology. 17 (8), pp. 1127-1136. [Online].